MedTrace Logo

High and Low Resource Interventions to Promote HPV Vaccines

NCT03824093 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 225

Last updated 2021-01-20

No results posted yet for this study

Summary

Human Papillomavirus (HPV) is a significant public health issue affecting nearly 14 million people in the United States. HPV can lead to cervical, oropharyngeal, anal, and penile cancers as well as genital warts.The purpose of this study is to test the comparative effectiveness of two interventions, AFIX only vs. AFIX + communication training, to increase Human Papillomavirus (HPV) vaccination rates among adolescent patients in outpatient clinic settings. Providers and staff at four pediatric practices will be randomized to receive an in-person AFIX consultation or an AFIX consultation combined with communication training and commitment poster displays. Provider and parent data will be collected via a tablet computer RedCap survey. Additional practice and provider level HPV vaccination rates will be collected via patient de-identified claims data. The results of this study could contribute to the existing body of literature that suggests provider recommendations and routine vaccination assessments are key to increasing HPV vaccination uptake. This project has the potential to lead to the implementation and dissemination of low resource interventions to increase HPV vaccination rates among children and adolescents.

Conditions

  • Human Papilloma Virus
  • Tdap - Tetanus, Diphtheria and Acellular Pertussis Vaccination
  • Meningitis, Meningococcal
  • Communication
  • Satisfaction

Interventions

BEHAVIORAL

AFIX Only

The intervention will include an in-person AFIX assessment of the practice's adolescent vaccination rates.

BEHAVIORAL

AFIX+ Provider Communication Training

The intervention will include an in-person AFIX assessment of the practice's adolescent vaccination rates along with communication training for providers and poster and brochure displays.

Sponsors & Collaborators

  • University of Kansas Medical Center

    collaborator OTHER

  • Midwest Cancer Alliance

    collaborator UNKNOWN

  • Children's Mercy Hospital Kansas City

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2020-05-06
Completion
2020-05-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03824093 on ClinicalTrials.gov